Athena Capital (South Africa)
Athena Capital (Pty) Ltd is a venture capital and private equity firm based in Cape Town, South Africa, with additional offices in Johannesburg and London. Established in 2003, the firm specializes in investments across various stages, including early-stage and middle-market acquisitions, with a particular focus on sectors such as energy and resources, financial services, agribusiness, and manufacturing. Athena Capital primarily targets opportunities in Sub-Saharan Africa, Europe, and Scandinavia, seeking platform companies that can leverage government and development finance support. The firm aims to secure board representation in its portfolio companies and is also involved in financial advisory services, offering transaction advisory for private equity, mezzanine debt, and trade finance. The firm has an established track record and a clear focus on sectors that align with its investment strategy.
Top Stages
3 past transactions
BioNTech
Series B in 2019
BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.
ComboCap Health
Private Equity Round in 2017
ComboCap Health, established in 2012 and headquartered in Whippany, New Jersey, is a technology-driven company serving the global pharmaceutical and nutraceutical industries. It specializes in the research and manufacturing of a unique dual-chamber oral capsule with a movable membrane, designed to enhance bioavailability, stability, and combination of substances. This innovative product enables clients to create advanced formulations for dietary supplements, pharmaceuticals, over-the-counter products, and combination therapies. As a subsidiary of Binutra Holdings, ComboCap Health operates as a biotechnology company dedicated to developing dual-delivery health products.
Nurevas
Private Equity Round in 2011
Nurevas is a food processing company that specializes in the manufacturing and marketing of a diverse array of processed food products. It serves both retail and catering sectors, offering a wide range of items including sauces, condiments, spreads, mayonnaise, and tomato-based products. Nurevas focuses on providing consumers with healthy and safe food options at affordable prices, catering to the demands of modern dietary preferences while ensuring quality in its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.